dexamethasone implant Ozurdex
Selected indexed studies
- Reverse engineering the Ozurdex dexamethasone intravitreal implant. (Int J Pharm, 2023) [PMID:36690129]
- Dexamethasone intravitreal implant (OZURDEX(®)) for macular edema secondary to noninfectious uveitis: a review of the literature. (Ther Deliv, 2019) [PMID:31184554]
- OZURDEX® (Dexamethasone Intravitreal Implant) 0.7 mg as Initial Therapy in Pseudophakic Patients With Diabetic Macular Edema, Macular Edema Following Retinal Vein Occlusion, and Noninfectious Posterior Segment Uveitis: A Case-Based Discussion. (Retina, 2019) [PMID:31206423]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Dexamethasone intravitreal implant (OZURDEX(®)) for macular edema secondary to noninfectious uveitis: a review of the literature. (2019) pubmed
- OZURDEX® (Dexamethasone Intravitreal Implant) 0.7 mg as Initial Therapy in Pseudophakic Patients With Diabetic Macular Edema, Macular Edema Following Retinal Vein Occlusion, and Noninfectious Posterior Segment Uveitis: A Case-Based Discussion. (2019) pubmed
- Reverse engineering the Ozurdex dexamethasone intravitreal implant. (2023) pubmed
- CASE REPORT OF ABIOTROPHIA DEFECTIVA ENDOPHTHALMITIS AFTER REPEATED INJECTIONS OF DEXAMETHASONE INTRAVITREAL IMPLANT (OZURDEX). (2022) pubmed
- Efficacy of Intravitreal Dexamethasone Implant (Ozurdex(®)) in Naïve and Refractory Patients with Different Morphological Subtypes of Diabetic Macular Edema. (2025) pubmed
- Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment. (2016) pubmed
- PERSISTENT REMNANTS OF DEXAMETHASONE INTRAVITREAL IMPLANT (OZURDEX). (2020) pubmed
- Protracted Intralenticular Implant of Sustained-Release Dexamethasone Implant (Ozurdex). (2024) pubmed
- Intraoperative Dexamethasone Intravitreal Implant (Ozurdex) in Vitrectomy Surgery for Epiretinal Membrane. (2020) pubmed
- Spontaneous extrusion of a dexamethasone intravitreal implant (Ozurdex). (2020) pubmed